跳到正文
原文
Biotechnology Innovation Organization· @IAmBiotech · X·· 25 天前AI 评分8
AI 导读

BIO 生物技术创新组织在 #BIOPACE26 第二天会议上,由执行副总裁兼首席传播官 Sarah Alspach 开场,介绍脓毒症幸存者、截肢者权益倡导者兼作家 Katy Grainger 分享其抗生素耐药感染经历及确诊脓毒症的时刻。当日讨论转向患者与治疗之间日益增多的障碍,以及可能缓解这些障碍的政策解决方案。

正文

Day two at #BIOPACE26 is underway! Advocates filed in past our #FightofOurLives photo activation, sharing what they’re fighting for on the way into the morning’s first session.

Opening the morning is BIO’s Sarah Alspach, Executive Vice President and Chief Communications Officer, who introduced Katy Grainger - sepsis survivor, amputee advocate, and author, who shared her story of an antibiotic-resistant infection, the moment she learned it was sepsis, and the mission that followed: making sure others recognize the signs in time.

Today’s conversations turn to the barriers increasingly standing between patients and treatment - and the policy solutions that could ease them.

来源:Biotechnology Innovation Organization · x.com